Advisory Board

E. Jason Abel, M.D., F.A.C.S.
E. Jason Abel, M.D., F.A.C.S.

Associate Professor of Urology, University of Wisconsin School of Medicine and Public Health

Daniel George, M.D.
Daniel George, M.D.

Professor, Medicine and Surgery, Divisions of Medical Oncology and Urology, Duke University School of Medicine; Director of Genitourinary Oncology, Duke Cancer Institute

Rana McKay, M.D.
Rana McKay, M.D.

Associate Professor of Medicine and Urology, University of California, San Diego; Co-Leader of Genitourinary Oncology Disease Team, Moores Cancer Center

Dror Michaelson, M.D., Ph.D. (Chair)
Dror Michaelson, M.D., Ph.D. (Chair)

Assoc. Professor of Medicine, Harvard Medical School; Director, Genitourinary Cancer Center, Massachusetts General Hospital

Elizabeth Plimack, M.D., M.S.
Elizabeth Plimack, M.D., M.S.

Professor of Hematology/Oncology and Division Chief of Genitourinary Medical Oncology, Fox Chase Cancer Center

Mark Ratain, M.D.
Mark Ratain, M.D.

Professor of Medicine, University of Chicago; Director of the Center for Personalized Medicine and Associate Director for Clinical Sciences, University of Chicago Comprehensive Cancer Center; Chief of Hospital Pharmacology, University of Chicago Medical Center

Brian Rini, M.D.
Brian Rini, M.D.

Professor of Medicine and Chief of Clinical Trials, Vanderbilt-Ingram Cancer Center

Yu Shyr, Ph.D.
Yu Shyr, Ph.D.

Professor of Biostatistics, Biomedical Informatics, Cancer Biology and Health Policy, Radiation Oncology and Immunology, Vanderbilt University Medical Center; Director, Vanderbilt Center for Quantitative Sciences; Director, Vanderbilt Technologies for Advanced Genomics Analysis and Research Design; Associate Director, Quantitative Sciences Integration, Vanderbilt-Ingram Cancer Center

M. Celeste Simon, Ph.D.
M. Celeste Simon, Ph.D.

Professor of Cell and Developmental Biology, University of Pennsylvania School of Medicine; Scientific Director, Abramson Family Cancer Research Institute